Skip to Content

Tritec (ranitidine bismuth citrate) Disease Interactions

There are 3 disease interactions with Tritec (ranitidine bismuth citrate):

Major

H2 Antagonists (Includes Tritec) ↔ Gi Bleeding

Severe Potential Hazard, Moderate plausibility

Applies to: Gastrointestinal Hemorrhage

Histamine H2 receptor antagonists should not be used in the presence of vomit with blood, or bloody or black stools. These might be serious conditions and the diagnosis needs to be ruled out.

Major

Ranitidine Bismuth Citrate (Includes Tritec) ↔ Porphyria

Severe Potential Hazard, Moderate plausibility

Applies to: Porphyria

Ranitidine may rarely precipitate acute porphyria attacks. Therapy with ranitidine bismuth citrate should be avoided in patients with a history of acute porphyria.

References

  1. "Product Information. Tritec (ranitidine bismuth citrate)." Glaxo Wellcome, Research Triangle Park, NC.
Moderate

Ranitidine Bismuth Citrate (Includes Tritec) ↔ Renal Dysfunction

Moderate Potential Hazard, High plausibility

Applies to: Renal Dysfunction

Ranitidine bismuth citrate is primarily eliminated by the kidney. Therapy with ranitidine bismuth citrate should be administered cautiously in patients with renal impairment, and avoided in patients with creatinine clearance < 25 mL/min.

References

  1. Lacey LF, Frazer NM, Keene ON, Smith JT "Comparative pharmacokinetics of bismuth from ranitidine bismuth citrate (GR122311X), a novel anti-ulcerant and tripotassium dicitrato bismuthate (TDB)." Eur J Clin Pharmacol 47 (1994): 177-80
  2. "Product Information. Tritec (ranitidine bismuth citrate)." Glaxo Wellcome, Research Triangle Park, NC.

Tritec (ranitidine bismuth citrate) drug Interactions

There are 268 drug interactions with Tritec (ranitidine bismuth citrate)

Tritec (ranitidine bismuth citrate) alcohol/food Interactions

There is 1 alcohol/food interaction with Tritec (ranitidine bismuth citrate)

Drug Interaction Classification

The classifications below are a general guideline only. It is difficult to determine the relevance of a particular drug interaction to any individual given the large number of variables.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No information available.

Do not stop taking any medications without consulting your healthcare provider.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide